Qure.ai and xWave collaborate to create efficiencies in the radiology pathway

Provider of medical AI solutions Qure.ai and xWave Technologies, which has developed a cloud-based clinical decision support (CDS) system for radiology referrals, have entered into a strategic partnership. They will focus on enhancing market access, product co-development and integration in order to identify opportunities to deliver advanced healthcare solutions globally that address critical healthcare challenges.

Qure.ai senior vice president and commercial head UK and Europe Darren Stephens stated: “Together, Qure and xWave can create patient-centric efficiencies in the radiology pathway. By dovetailing clinical decision support with AI in imaging, clinicians will be further supported. Patients will gain quicker results and imaging departments will see reduced demand for unnecessary diagnostic appointments. This will help to slow the growth of waiting lists, particularly in the NHS. Ordering the right test, first time, along with the efficiency gains of AI, will provide hospitals with powerful support when looking ahead to winter healthcare pressures.”

Qure.ai’s certified medical imaging AI solutions for neurocritical trauma or stroke CTs, musculoskeletal x-ray fracture detection and chest x-ray/CT for detection of lung cancer, TB or heart failure are used in collaboration with more than 25 NHS trusts and health boards in the UK.

xWave’s CDS system has been developed in partnership with the European Society of Radiology (iGuide) and The Royal College of Radiologists (iRefer) to guide clinical referrers to order the best test for patients.

Picture: Qure.ai senior vice president and commercial head UK and Europe Darren Stephens and xWave Technologies ceo Mitchell O’Gorman.

Published on page 13 of the October 2023 issue of RAD Magazine.